Accordingly, MDA-MB-231 breast cancer cells present a uniquely suitable model system for investigating the involvement of CXCR4 and CXCR3 receptors in the CXCL4–CXCL12 heterodimer signaling. This evidence concerns the gene CXCL12 and breast cancer.